Staff Reporters
Oct 20, 2010

Pharma giant Sanofi-Aventis retains Optimedia for US$450m media

GLOBAL - Sanofi-Aventis has retained Publicis Groupe's Optimedia for its global media account following a review.

Pharma giant Sanofi-Aventis retains Optimedia for US$450m media

The worldwide worth of the French pharmaceutical giant’s media spend is put at US$450 million, based on Nielsen estimates.

A review was reportedly held at the company’s headquarters in Paris, other agencies involved were not disclosed.

Sanofi-Aventis brands include Plavix, Lantus, Maalox, Frontline and Heartgard.

Source:
Campaign Asia

Related Articles

Just Published

1 day ago

Brands plan for a quiet Pride Month

Agencies report dwindling projects and an overall lack of communication from clients regarding Pride Month plans.

1 day ago

Bosch partners with Amnet and Samsung for weather-ac...

The initiative harnesses weather API and CTV to boost awareness of Bosch's new machines, with impressive results in Mumbai.

1 day ago

Havas Worldwide retains Durex creative duties

As reported earlier by Campaign India, the pitch had several big-ticket agencies vying for the plum account alongside the incumbent.

1 day ago

Queer Ad Folk: Good allies must call out the ...

Deborah Whitfield, head of production and executive producer, Factory Studios, shares her experience.